Hypertension Diagnostics, Inc.


	Hypertension Diagnostics Announces Second Quarter FY 2006 Results ST. PAUL, MN – February 14, 2006 – Hypertension Diagnostics, Inc. (OTC: HDII.OB), today announced financial results for the second quarter of fiscal year 2006 ended December 31, 2005. The Company was cash flow positive for the quarter, generating cash from operations without the benefit of financing activities. The Company reported a cash balance of $1,211,717 on December 31, 2005, compared to a reported cash balance of $1,169,653 as of September 30, 2005.
	Revenue for the quarter totaled $541,106 compared to $292,015 in the prior year’s second quarter ended December 31, 2004, which represents an 85% increase. The Company incurred a net loss of $283,927 for the quarter or $(.01) per share compared with a net loss of $439,768 for the prior year’s quarter or $(.02) per share. Total tests transmitted, a key metric for gauging customer usage, was 7,660 for the quarter, a 63% increase from the prior year’s quarterly transmissions. For the six month period ended December 31, 2005, total revenue was $922,022, compared to $545,436 for the same period one year ago, a 69% increase. For the six month period ended December 31, 2005, the Company incurred a net loss of $621,144, or $(.02) per share, compared with a net loss of $874,247, or $(.03) per share, for the same period one year ago. “This was a pivotal quarter for the Company,” commented CEO Mark Schwartz. “We are beginning to see the results of our team’s hard work and the market’s acceptance of our technology,” added Mr. Schwartz. The Company has scheduled a conference call to discuss its quarterly financial results on Tuesday, February 14th, at 4:00 PM Central Time. Please contact the Company at 888-687-9999 x106 for conference call information. Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company’s 2005 Annual Report on Form 10-KSB, and subsequent Quarterly Reports on 10-QSB, all of which were filed with the U.S. Securities and Exchange Commission, as well as others not now anticipated. View PDF file: Second Quarter FY 2006 Results CVProfilor is a registered trademark of Hypertension Diagnostics, Inc. Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved. Website: www.HDII.com Contact: Mark Schwartz, CEO 651-687-9999 Return to the Main HDI Newsroom Back to Top

Copyright © 2010 Hypertension Diagnostics, Inc Last revised Wednesday June 23, 2010 HDI Legal Information